Citrocine

Citrocin is a potent bacterial RNA polymerase (RNAP) inhibitor. Citrocin shows significant inhibitory activity against Escherichia coli RNAP with an MIC range of 16-125 μM. Citrocin specifically binds to and inhibits RNA polymerase to block bacterial transcription and enters cells mainly through inner membrane protein SbmA. Citrocin is promising for research of Gram-negative bacterial infections, such as enterohemorrhagic E. coli[1].

12352209

Bacterial

Anti-infection

COVID-19-anti-virus

Infection

O=C(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC1)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H]([C@@H](C)CC)C(NCC(NCC(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CC=C(C=C4)O)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CNC1=O

C88H133N23O23

1881.14

[1]Cheung-Lee WL, et al. Discovery and structure of the antimicrobial lasso peptide citrocin. J Biol Chem. 2019 Apr 26;294 (17) :6822-6830.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P10980/

Peptides

No Development Reported